Advanced search
Publication Cover
Clinical Toxicology Volume 56, 2018 - Issue 6
Submit an article Journal homepage
4,821
Views
18
CrossRef citations to date
0
Altmetric
Clinical Research

The safety of high-dose insulin euglycaemia therapy in toxin-induced cardiac toxicity

Colin B. PageClinical Toxicology Research Group, University of Newcastle, Newcastle, Australia; ;School of Medicine, University of Queensland, Brisbane, Australia; ;Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Newcastle, AustraliaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-6924-8130
ORCID Icon,
Nicole M. RyanClinical Toxicology Research Group, University of Newcastle, Newcastle, Australia; ORCID Iconhttp://orcid.org/0000-0003-0334-1938
ORCID Icon &
Geoffrey K. IsbisterClinical Toxicology Research Group, University of Newcastle, Newcastle, Australia; ;Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Newcastle, AustraliaORCID Iconhttp://orcid.org/0000-0003-1519-7419
ORCID Icon
Pages 389-396 | Received 26 Jun 2017, Accepted 09 Oct 2017, Published online: 26 Oct 2017

References

  • Kline JA, Tomaszewski CA, Scsoeder JD, et al. Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine. J Pharmacol Exp Ther. 1993;267:744–750.
  • Kline JA, Leonova E, Raymond RM. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med. 1995;23:1251–1263.
  • Kline JA, Raymond RM, Leonova ED, et al. Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines. Cardiovasc Res. 1997;34:289–298.
  • Yuan TH, Kerns WP 2nd, Tomaszewski CA, et al. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol. 1999;37:463–474.
  • Abeysinghe N, Aston J, Polouse S. Diltiazem overdose: a role for high-dose insulin. Emerg Med J. 2010;27:802–803.
  • Nickson CP, Little M. Early use of high-dose insulin euglycaemic therapy for verapamil toxicity. Med J Aust. 2009;191:350–352.
  • Greene SL, Gawarammana I, Wood DM, et al. Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study. Intensive Care Med. 2007; 33:2019–2024.
  • Page C, Hacket LP, Isbister GK. The use of high-dose insulin-glucose euglycemia in beta-blocker overdose: a case report. J Med Toxicol. 2009;5:139–143.
  • Holger JS, Engebretsen KM, Marini JJ. High dose insulin in toxic cardiogenic shock. Clin Toxicol. 2009;47:303–307.
  • Holger JS, Stellpflug SJ, Cole JB, et al. High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock. Clin Toxicol. 2011;49:653–658.
  • Isbister GK, Sellors KV, Beckmann U, et al. Catecholamine-induced cardiomyopathy resulting from life-threatening funnel-web spider envenoming. Med J Aust. 2015;203:302–304.
  • DeWitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev. 2004;23:223–238.
  • Kerns W 2nd. Management of beta-adrenergic blocker and calcium channel antagonist toxicity. Emerg Med Clin North Am. 2007;25:309–331.
  • Graudins A, Lee HM, Druda D. Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. Br J Clin Pharmacol. 2016;81:453–461.
  • Levine M, Boyer EW, Pozner CN, et al. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med. 2007;35:2071–2075.
  • Lheureux PE, Zahir S, Gris M, et al. Bench-to-bedside review: hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers. Crit Care. 2006;10:212.
  • Holger JS, Engebretsen KM, Fritzlar SJ, et al. Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. Clin Toxicol. 2007;45:396–401.
  • Cole JB, Stellpflug SJ, Ellsworth H, et al. A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock. Clin Toxicol. 2013;51:201–207.
  • Engebretsen KM, Kaczmarek KM, Morgan J, et al. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol. 2011;49:277–283.
  • Hypomagnesaemia. Drug Ther Bull. 2013;51:33–36.
  • Gaasbeek A, Meinders AE. Hypophosphatemia: an update on its etiology and treatment. Am J Med. 2005;118:1094–1101.
  • Medford-Davis L, Rafique Z. Derangements of potassium. Emerg Med Clin North Am. 2014;32:329–347.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.